康复过渡计划改善卒中幸存者社区参与:一项随机临床试验
这项2b期平行随机临床试验纳入185例50岁以上、卒中前日常生活活动独立、计划出院的急性缺血性卒中或脑出血患者,比较COMPASS(家庭改造与策略训练)与注意力对照的疗效。主要结局社区参与(Reintegration to Normal Living Index)在12个月时两组均改善,无显著组间效应(均差0.3;95%CI -4.6至5.2;P=.91)或组×时间交互效应(组间变化差1.3;95%CI -7.1至9.6;P=.76)。COMPASS组在I-HOPE活动表现(组间变化差0.39;95%CI 0.01-0.77;P=.046)和满意度(0.52;95%CI 0.08-0.96;P=.02)上改善更大,环境障碍改善也更显著(交互P=.003),6个月时差异最大(组间变化差-15.3;95%CI -24.4至-6.2)。
要点
- COMPASS组与对照组12个月社区参与(Reintegration to Normal Living Index)均改善,无显著组间效应(均差0.3;95%CI -4.6至5.2;P=.91)或组×时间交互效应(组间变化差1.3;95%CI -7.1至9.6;P=.76)。
- COMPASS组12个月I-HOPE活动表现改善大于对照组(组间变化差0.39;95%CI 0.01-0.77;P=.046)。
- COMPASS组12个月I-HOPE满意度改善大于对照组(组间变化差0.52;95%CI 0.08-0.96;P=.02)。
- COMPASS组I-HOPE环境障碍改善大于对照组(交互P=.003),6个月时差异最大(组间变化差-15.3;95%CI -24.4至-6.2)。
- COMPASS包含家庭改造与策略训练,研究人群为50岁以上、卒中前ADL独立、计划出院的急性缺血性卒中或脑出血患者。
适用人群与场景
- 纳入标准:50岁及以上,经历急性缺血性卒中或脑出血,卒中前日常生活活动独立,计划出院回家。
- 研究场所:密苏里州圣路易斯的住院康复机构及患者家中。
- 研究时间:2018年1月9日至2023年12月20日。
处置流程与药物剂量
- COMPASS干预包括家庭改造和策略训练。
研究设计与关键结果
- 研究类型:2b期平行随机临床试验;样本量185例(COMPASS组85例,对照组100例);平均(SD)年龄66.3(9.0)岁;男性105例(56.8%)。
- 主要结局:12个月社区参与(Reintegration to Normal Living Index)两组均改善,无显著组间效应(均差0.3;95%CI -4.6至5.2;P=.91)或组×时间交互效应(组间变化差1.3;95%CI -7.1至9.6;P=.76)。
- 关键次要结局:12个月I-HOPE活动表现组间变化差0.39(95%CI 0.01-0.77;P=.046),满意度组间变化差0.52(95%CI 0.08-0.96;P=.02),均为COMPASS组改善更大。
- 环境障碍:COMPASS组I-HOPE环境障碍改善大于对照组(交互P=.003),6个月时差异最大(组间变化差-15.3;95%CI -24.4至-6.2)。
证据类型、等级与局限
- 证据类型:随机临床试验(2b期)。
- 试验注册:ClinicalTrials.gov Identifier: NCT03485820。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于50岁及以上、卒中前ADL独立、计划从住院康复出院的急性缺血性卒中或脑出血患者,COMPASS未显著改善12个月社区参与,但改善了自我评定的日常活动表现与满意度,并减少了环境障碍。
- COMPASS包含家庭改造与策略训练,作者认为COMPASS减少了卒中幸存者从住院康复过渡到家庭期间的环境障碍并改善了日常活动表现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Interventions are needed to support the long-term needs of stroke survivors when they transition from inpatient rehabilitation to home, where they face new home and community environmental barriers.
OBJECTIVE: To compare the efficacy of a novel, enhanced rehabilitation transition program with attentional control to improve community participation and activity of daily living (ADL) performance and to reduce environmental barriers in the home and community after stroke.
DESIGN, SETTING, AND PARTICIPANTS: This phase 2b, parallel randomized clinical trial assessed patients 50 years or older who had experienced an acute ischemic stroke or intracerebral hemorrhage, were independent in ADLs before stroke, and planned to be discharged home. Patients were assessed at an inpatient rehabilitation facility in St Louis, Missouri, and their homes from January 9, 2018, to December 20, 2023.
INTERVENTION: Community Participation Transition after Stroke (COMPASS), including home modifications and strategy training.
MAIN OUTCOMES AND MEASURES: The primary outcome was community participation (Reintegration to Normal Living Index). Secondary outcomes were daily activity performance (Stroke Impact Scale ADL domain and the In-Home Occupational Performance Evaluation [I-HOPE] activity, performance, and satisfaction scores) and environmental barriers in the home (I-HOPE environmental barriers score).
RESULTS: A total of 185 participants (mean [SD] age, 66.3 [9.0] years; 105 [56.8%] male) were randomized (85 to the COMPASS group and 100 to the control group). The COMPASS and control participants experienced similar improvements in community participation by 12 months, with no significant group (mean difference, 0.3; 95% CI, -4.6 to 5.2; P = .91) or group × time interaction (between-group differences in changes over time, 1.3; 95% CI, -7.1 to 9.6; P = .76) effects. Improvements in I-HOPE performance and satisfaction scores were greater for COMPASS participants than control participants at 12 months (between-group differences in changes for performance: 0.39; 95% CI, 0.01-0.77; P = .046; satisfaction: 0.52; 95% CI, 0.08-0.96; P = .02). The COMPASS participants had greater improvements for I-HOPE environmental barriers than the control participants (P = .003 for interaction), with the largest differences at 6 months (between-group differences in changes: -15.3; 95% CI -24.4 to -6.2).
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial of stroke survivors, participants in both groups experienced improvements in community participation. COMPASS participants had greater improvements in self-rated performance and satisfaction with performing daily activities as well as a greater reduction in environmental barriers than control participants. COMPASS reduced environmental barriers and improved performance of daily activities for stroke survivors as they transitioned from inpatient rehabilitation to home.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03485820.
参考来源
- Bollinger RM, Krauss MJ, Somerville EK, et al. Rehabilitation Transition Program to Improve Community Participation Among Stroke Survivors: A Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 39374016. doi:10.1001/jamanetworkopen.2024.37758
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。